SHENZHEN, China, Aug. 31 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS.PK) www.htdsmedical.com - is pleased to announce today that Mellow Hope, an operating subsidiary of HTDS, is providing another government tender. This one is for 50,000 doses of Mevac A in Sri Lanka. Mellow Hope maintains a good relationship with a local partner, who is one of the leading pharmaceutical companies in Sir Lanka.
Mr. Terry Yuan, CEO of HTDS, said "Although these are tenders they are worthwhile mentioning especially when our confidence is high that we will be awarded this tender. We are hoping to be in a position to release the results October 2009 for Sri Lanka. Just as we announced our Chile tender (see news Aug 07, 2009), we are pleased to announce that significant strides were made on that front as well. Because this is a significant deal (the largest single order the company will fulfill to date), these strides required my attendance in Chile this week to iron out any fine details which may remain outstanding. Regrettably due to the sudden required trip to Chile, I was unable due to scheduling to attend the Expo in Toronto Canada where HTDS' interests in Slavica Bio Chem and Mellow Hope were proudly exhibited by our Science correspondent for our shareholders, and other professionals that attended the event. Now, subsequent to the Expo we have received many inquiries where amongst other things, shareholders were concerned about certain "reports" that were being posted or circulating on the Internet that some individuals have "met with CEO of HTDS" and the prognoses for HTDS is not good, and other similar falsehoods. Again, I was unable due to scheduling to attend the Expo in Toronto, and no such conversation took place, nor is there any truth to it. I know that our investor relations company (Mina Mar Group) takes these matters quite seriously and takes legal action against t
'/>"/>
| SOURCE Hard to Treat Diseases Copyright©2009 PR Newswire. All rights reserved |